To further manifest the effect of NMHC on tumor development, we assessed tumor cell proliferation and apoptosis in vivo, and detected decreased PCNA and enhanced cleaved Caspase-3 expression from the compound-treated tumors (Fig. 6e,f). This evidence concerns the gene CASP3 and neoplasm.